Literature DB >> 23821307

Progestin-only contraceptives: effects on weight.

Laureen M Lopez1, Alison Edelman, Mario Chen, Conrad Otterness, James Trussell, Frans M Helmerhorst.   

Abstract

BACKGROUND: Progestin-only contraceptives (POCs) are appropriate for many women who cannot or should not take estrogen. Many POCs are long-acting, cost-effective methods of preventing pregnancy. However, concern about weight gain can deter the initiation of contraceptives and cause early discontinuation among users.
OBJECTIVES: The primary objective was to evaluate the association between progestin-only contraceptive use and changes in body weight. SEARCH
METHODS: Through May 2013, we searched MEDLINE, CENTRAL, POPLINE, LILACS, ClinicalTrials.gov, and ICTRP. The 2010 search also included EMBASE. For the initial review, we contacted investigators to identify other trials. SELECTION CRITERIA: All comparative studies were eligible that examined a POC versus another contraceptive method or no contraceptive. The primary outcome was mean change in body weight or mean change in body composition. We also considered the dichotomous outcome of loss or gain of a specified amount of weight. DATA COLLECTION AND ANALYSIS: Two authors extracted the data. We computed the mean difference (MD) with 95% confidence interval (CI) for continuous variables. For dichotomous outcomes, the Mantel-Haenszel odds ratio (OR) with 95% CI was calculated. MAIN
RESULTS: We found 16 studies; one examined progestin-only pills, one studied the levonorgestrel-releasing intrauterine system (LNG-IUS), four examined an implant, and 10 focused on depot medroxyprogesterone acetate (DMPA). Outcomes examined were changes in body weight only (14 studies), changes in both body weight and body composition (1 study), and changes in body composition only (1 study). We did not conduct meta-analysis due to the various contraceptive methods and weight change measures.Comparison groups did not differ significantly for weight change in 12 studies. However, three studies showed weight change differences for POC users compared to women not using a hormonal method. In one study, weight gain (kg) was greater for the DMPA group than the group using a non-hormonal IUD in years one through three [(MD 2.28; 95% CI 1.79 to 2.77), (MD 2.71, 95% CI 2.12 to 3.30), and (MD 3.17; 95% CI 2.51 to 3.83), respectively]. The differences were notable within the normal weight and overweight subgroups. Two implant studies also showed differences in weight change. The implant group (six-capsule) had greater weight gain (kg) compared to the group using a non-hormonal IUD in both studies [(MD 0.47 (95% CI 0.29 to 0.65); (MD 1.10; 95% CI 0.36 to 1.84)]. In one of those studies, the implant group also had greater weight gain than a group using a barrier method or no contraceptive (MD 0.74; 95% CI 0.52 to 0.96).The two studies that assessed body composition change showed differences between POC users and women not using a hormonal method. Adolescents using DMPA had a greater increase in body fat (%) compared to a group not using a hormonal method (MD 11.00; 95% CI 2.64 to 19.36). The DMPA group also had a greater decrease in lean body mass (%) (MD -4.00; 95% CI -6.93 to -1.07). The other study reported differences between an LNG-IUS group and a non-hormonal IUD group in percent change in body fat mass (2.5% versus -1.3%, respectively; reported P value = 0.029) and percent change in lean body mass (-1.4% versus 1.0%, respectively; reported P value = 0.027). AUTHORS'
CONCLUSIONS: The overall quality of evidence was moderate to low, given that the studies were evenly divided across the evidence quality groups (high, moderate, low, or very low quality). We found limited evidence of weight gain when using POCs. Mean gain was less than 2 kg for most studies up to 12 months. Weight change for the POC group generally did not differ significantly from that of the comparison group using another contraceptive. Two studies that assessed body composition showed that POC users had greater increases in body fat and decreases in lean body mass compared to users of non-hormonal methods. Appropriate counseling about typical weight gain may help reduce discontinuation of contraceptives due to perceptions of weight gain.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23821307      PMCID: PMC3855691          DOI: 10.1002/14651858.CD008815.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  69 in total

Review 1.  Progestin-only pills for contraception.

Authors:  David A Grimes; Laureen M Lopez; Paul A O'Brien; Elizabeth G Raymond
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

2.  Contraceptive use and contraception type in women by body mass index category.

Authors:  Amisha Schraudenbach; Stephanie McFall
Journal:  Womens Health Issues       Date:  2009 Nov-Dec

3.  Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.

Authors:  M Valeria Bahamondes; Ilza Monteiro; Sara Castro; Ximena Espejo-Arce; Luis Bahamondes
Journal:  Hum Reprod       Date:  2010-02-25       Impact factor: 6.918

4.  Relationship between weight and bone mineral density in adolescents on hormonal contraception.

Authors:  Andrea E Bonny; Michelle Secic; Barbara A Cromer
Journal:  J Pediatr Adolesc Gynecol       Date:  2010-08-14       Impact factor: 1.814

5.  Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception.

Authors:  Mags E Beksinska; Jenni A Smit; Immo Kleinschmidt; Cecilia Milford; Timothy M M Farley
Journal:  Contraception       Date:  2010-01       Impact factor: 3.375

6.  [Variation of weigth among users of the contraceptive with depot-medroxyprogesterone acetate according to body mass index in a six-year follow-up].

Authors:  Márcia Pantoja; Tatiane Medeiros; Maria Carolina Baccarin; Sirlei Morais; Arlete Maria dos Santos Fernandes
Journal:  Rev Bras Ginecol Obstet       Date:  2009-08

7.  Contraceptive use by obese women 1 year postpartum.

Authors:  Jeanette R Chin; Geeta K Swamy; Truls Østbye; Lori A Bastian
Journal:  Contraception       Date:  2009-05-09       Impact factor: 3.375

8.  A longitudinal comparison of body composition changes in adolescent girls receiving hormonal contraception.

Authors:  Andrea E Bonny; Michelle Secic; Barbara A Cromer
Journal:  J Adolesc Health       Date:  2009-06-21       Impact factor: 5.012

9.  Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091.

Authors:  Susan Higginbotham
Journal:  Contraception       Date:  2009-09-24       Impact factor: 3.375

10.  Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive.

Authors:  Márcia Pantoja; Tatiane Medeiros; Maria Carolina Baccarin; Sirlei Siani Morais; Luis Bahamondes; Arlete Maria dos Santos Fernandes
Journal:  Contraception       Date:  2009-12-02       Impact factor: 3.375

View more
  14 in total

Review 1.  Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.

Authors:  Valentina Medici; Stephen A McClave; Keith R Miller
Journal:  Curr Gastroenterol Rep       Date:  2016-01

Review 2.  Obesity and contraception.

Authors:  Sheila K Mody; Michelle Han
Journal:  Clin Obstet Gynecol       Date:  2014-09       Impact factor: 2.190

Review 3.  Ovarian hormones and obesity.

Authors:  Brigitte Leeners; Nori Geary; Philippe N Tobler; Lori Asarian
Journal:  Hum Reprod Update       Date:  2017-05-01       Impact factor: 15.610

4.  Incidence of Discontinuation of Long-Acting Reversible Contraception among Adolescent and Young Adult Women Served by an Urban Primary Care Clinic.

Authors:  Katharine K Sznajder; Kathy S Tomaszewski; Anne E Burke; Maria Trent
Journal:  J Pediatr Adolesc Gynecol       Date:  2016-07-14       Impact factor: 1.814

5.  Changes in body composition in women using long-acting reversible contraception.

Authors:  Priscilla de Nazaré Silva Dos Santos; Tessa Madden; Karen Omvig; Jeffrey F Peipert
Journal:  Contraception       Date:  2016-12-30       Impact factor: 3.375

Review 6.  Hormonal contraceptives for contraception in overweight or obese women.

Authors:  Laureen M Lopez; Alissa Bernholc; Mario Chen; Thomas W Grey; Conrad Otterness; Carolyn Westhoff; Alison Edelman; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2016-08-18

7.  5As Team obesity intervention in primary care: development and evaluation of shared decision-making weight management tools.

Authors:  A M Osunlana; J Asselin; R Anderson; A A Ogunleye; A Cave; A M Sharma; D L Campbell-Scherer
Journal:  Clin Obes       Date:  2015-06-30

Review 8.  Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome.

Authors:  Young-Mo Yang; Eun Joo Choi
Journal:  Ther Clin Risk Manag       Date:  2015-09-01       Impact factor: 2.423

Review 9.  Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits.

Authors:  Anderson Sanches de Melo; Rosana Maria Dos Reis; Rui Alberto Ferriani; Carolina Sales Vieira
Journal:  Open Access J Contracept       Date:  2017-02-02

Review 10.  Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery.

Authors:  Clarissa Lam; Amitasrigowri S Murthy
Journal:  Open Access J Contracept       Date:  2016-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.